Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study

Marius M. Hoeper, Robyn J. Barst, Robert C. Bourge, Jeremy Feldman, Adaani E. Frost, Nazzareno Galié, Miguel Angel Gómez-Sánchez, Friedrich Grimminger, Ekkehard Grünig, Paul M. Hassoun, Nicholas W. Morrell, Andrew J. Peacock, Toru Satoh, Gérald Simonneau, Victor F. Tapson, Fernando Torres, David Lawrence, Deborah A. Quinn, Hossein Ardeschir Ghofrani

Research output: Contribution to journalArticlepeer-review

358 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study'. Together they form a unique fingerprint.

Medicine & Life Sciences